Literature DB >> 8461626

Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population.

A Steinmetz1, A Kirklies, G Schlosser, W Cassel, J H Peter, K Ehlenz, J R Schäfer, P V Wichert, H Kaffarnik.   

Abstract

Both hypercholesterolemia and hypertension are risk factors for atherosclerotic vascular disease, and elevated cholesterol levels occur more frequently than expected in patients with hypertension. Elevated levels of intermediate-density lipoproteins (IDL) and low-density lipoproteins (LDL) were shown to be atherogenic, and LDL, comprising the major cholesterol-carrying fraction in human plasma, are structurally related to lipoprotein (a)[Lp(a)], a further risk factor for atherosclerosis. In the present study we investigated 200 male employees (mean age 26 +/- 7 years) to determine whether the relationship of IDL and Lp(a) to systemic blood pressure is similar to the reported correlations between total and LDL cholesterol and systemic blood pressure. To this end blood pressure was measured several times in each individual, and lipids, lipoprotein-cholesterol, apolipoprotein B (apo B), and Lp(a) were determined in fasting serum. IDL cholesterol and apo B, the main protein component of IDL and LDL correlated with blood pressure. However, levels of Lp(a) correlated neither with systolic or diastolic blood pressure nor with lipoprotein cholesterol, body weight, or age. Although IDL and Lp(a) are considered lipoprotein risk factors for atherosclerosis, levels of Lp(a), unlike IDL, are not related to blood pressure, body weight, or age. Our data suggest different metabolic and pathophysiological mechanisms of the risk factors, IDL, LDL, and Lp(a).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461626     DOI: 10.1007/bf00179996

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  22 in total

1.  Separation of plasma lipoproteins by density-gradient ultracentrifugation.

Authors:  T G Redgrave; D C Roberts; C E West
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

Review 2.  Lipids and the kidney.

Authors:  B L Kasiske; M P O'Donnell; W Cowardin; W F Keane
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

3.  Reduction of lipoprotein (a) by weight loss.

Authors:  A C Sönnichsen; W O Richter; P Schwandt
Journal:  Int J Obes       Date:  1990-06

4.  The association between blood pressure and serum cholesterol in healthy men: the Oslo study.

Authors:  I Hjermann; A Helgeland; I Holme; P G Lund-Larsen; P Leren
Journal:  J Epidemiol Community Health (1978)       Date:  1978-06

5.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

Authors:  M Sandkamp; H Funke; H Schulte; E Köhler; G Assmann
Journal:  Clin Chem       Date:  1990-01       Impact factor: 8.327

6.  Adrenergic mechanisms in the control of plasma lipids in man.

Authors:  J L Day; J Metcalfe; N Simpson; L Lowenthal
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

7.  Hypertension detection and follow-up program. Baseline laboratory examination characteristics of the hypertensive participants.

Authors:  M H Maxwell; E Fitzsimmons; R Harrist; J Hotchkiss; H G Langford; G H Payne; K A Schneider; P Varaday
Journal:  Hypertension       Date:  1983 Nov-Dec       Impact factor: 10.190

8.  A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.

Authors:  W P Castelli; K Anderson
Journal:  Am J Med       Date:  1986-02-14       Impact factor: 4.965

9.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

10.  Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population.

Authors:  J Heinrich; M Sandkamp; R Kokott; H Schulte; G Assmann
Journal:  Clin Chem       Date:  1991-11       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.